HER2-Targeted Therapies Summit 2022
Evvnt Promotion / evvnt
14.06.2022 - 16.06.2022 Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 09:00 - 17:00
Conference themes
The momentum in anti-HER2 drug development is exploding:
Outcomes for HER2-expressing breast cancer are patients constantly improving; diagnostics, trial design and innovative drug design are at an all-time high; complementing the newly accessible HER2 'low' space and wider range of tumor indications; the last year has given us more progress in HER2-targeted therapies than ever before.
The momentum in anti-HER2 drug development is exploding:
Outcomes for HER2-expressing breast cancer are patients constantly improving; diagnostics, trial design and innovative drug design are at an all-time high; complementing the newly accessible HER2 'low' space and wider range of tumor indications; the last year has given us more progress in HER2-targeted therapies than ever before.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Speakers: Cecile Geuijen Chief Scientific Officer and Vice President - Oncology, Merus, Shane Olwill Chief Development Officer, Senior Vice President and Head of Translational Science, Pieris Pharmaceuticals and more.
Speakers: Cecile Geuijen Chief Scientific Officer and Vice President - Oncology, Merus, Shane Olwill Chief Development Officer, Senior Vice President and Head of Translational Science, Pieris Pharmaceuticals and more.
Enquiries and Registration:
https://go.evvnt.com/1003520-2?pid=4832
Ms. Ellie Saunders
General Medicine
Languages
English
English
Congress fees
Industry Pricing - Conference + Workshop Day - Standard Rate: USD 4097.0, Industry Pricing - Conference Only - Standard Rate: USD 2899.0
Industry Pricing - Conference + Workshop Day - Standard Rate: USD 4097.0, Industry Pricing - Conference Only - Standard Rate: USD 2899.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
